40
Participants
Start Date
April 30, 2004
Primary Completion Date
March 15, 2026
Study Completion Date
March 15, 2026
Fulvestrant
500mg into the muscle on days 1, 15 and 29 and then every 28 days thereafter.
Massachusetts General Hosptial, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Lowell General Hospital, Lowell
South Shore Hospital, South Weymouth
Dana-Farber Cancer Institute
OTHER
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Lowell General Hospital
OTHER
University of Colorado, Denver
OTHER
University of Maryland Greenebaum Cancer Center
OTHER
South Shore Hospital
OTHER
Beth Israel Deaconess Medical Center
OTHER